Pharming PHAR
NASDAQ PHAR
$13.22 +0.06 (+0.46%)
At close: Nov 10, 2026 · 4:00 PM EST

Pharming (PHAR) Liabilities and Shareholders Equity (2019 - 2026)

Updated

Analysis

Pharming (PHAR) Liabilities and Shareholders Equity (2019 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn 148.07 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn 197.43 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn 147.68 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn 132.77 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn 122.03 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn 115.83 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn 96.05 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn 51.41 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn 205.00 Bn
10 Pharming 898.85 Mn 429.52 Mn - 499.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 496.64 Mn
Jun 30, 2026 468.00 Mn
Mar 31, 2026 489.37 Mn
Dec 31, 2025 499.96 Mn
Sep 30, 2025 473.79 Mn
Jun 30, 2025 446.30 Mn
Mar 31, 2025 403.18 Mn
Dec 31, 2024 399.99 Mn
Sep 30, 2024 425.51 Mn
Jun 30, 2024 415.93 Mn
Mar 31, 2024 441.67 Mn
Dec 31, 2023 462.85 Mn
Sep 30, 2023 436.47 Mn
Jun 30, 2023 429.81 Mn
Mar 31, 2023 423.00 Mn
Dec 31, 2022 425.80 Mn
Sep 30, 2022 382,323.00
Jun 30, 2022 393.90 Mn
Mar 31, 2022 392.80 Mn
Dec 31, 2021 397.32 Mn
API Access

Pharming Liabilities and Shareholders Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=PHAR&period=max&api_key=YOUR_API_KEY